Assessing therapeutic response non-invasively in a neonatal rat model of acute inflammatory white matter injury using high-field MRI
- PMID: 31247289
- DOI: 10.1016/j.bbi.2019.06.032
Assessing therapeutic response non-invasively in a neonatal rat model of acute inflammatory white matter injury using high-field MRI
Abstract
Perinatal infection and inflammatory episodes in preterm infants are associated with diffuse white matter injury (WMI) and adverse neurological outcomes. Inflammation-induced WMI was previously shown to be linked with later hippocampal atrophy as well as learning and memory impairments in preterm infants. Early evaluation of injury load and therapeutic response with non-invasive tools such as multimodal magnetic resonance imaging (MRI) would greatly improve the search of new therapeutic approaches in preterm infants. Our aim was to evaluate the potential of multimodal MRI to detect the response of interleukin-1 receptor antagonist (IL-1Ra) treatment, known for its neuroprotective properties, during the acute phase of injury on a model of neonatal WMI. Rat pups at postnatal day 3 (P3) received intracerebral injection of lipopolysaccharide with systemic IL-1Ra therapy. 24 h later (P4), rats were imaged with multimodal MRI to assess microstructure by diffusion tensor imaging (DTI) and neurochemical profile of the hippocampus with 1H-magnetic resonance spectroscopy. Astrocyte and microglial activation, apoptosis and the mRNA expression of pro-inflammatory and necroptotic markers were assessed. During the acute phase of injury, neonatal LPS exposure altered the concentration of hippocampus metabolites related to neuronal integrity, neurotransmission and membrane integrity and induced diffusivity restriction. Just 24 h after initiation of therapy, early indication of IL-1Ra neuroprotective effect could be detected in vivo by non-invasive spectroscopy and DTI, and confirmed with immunohistochemical evaluation and mRNA expression of inflammatory markers and cell death. In conclusion, multimodal MRI, particularly DTI, can detect not only injury but also the acute therapeutic effect of IL-1Ra suggesting that MRI could be a useful non-invasive tool to follow, at early time points, the therapeutic response in preterm infants.
Keywords: Diffusion tensor imaging; High-field MRI; IL-1Ra; In vivo imaging; Lipopolysaccharide; Magnetic resonance spectroscopy; Periventricular leukomalacia.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Non-invasive in vivo MRI detects long-term microstructural brain alterations related to learning and memory impairments in a model of inflammation-induced white matter injury.Behav Brain Res. 2022 Jun 25;428:113884. doi: 10.1016/j.bbr.2022.113884. Epub 2022 Apr 6. Behav Brain Res. 2022. PMID: 35398230
-
Magnesium sulfate (MG) prevents maternal inflammation induced offspring cerebral injury evident on MRI but not via IL-1β.Neuroscience. 2017 Jun 14;353:98-105. doi: 10.1016/j.neuroscience.2017.03.046. Epub 2017 Apr 12. Neuroscience. 2017. PMID: 28412496
-
Advanced MRI analysis to detect white matter brain injury in growth restricted newborn lambs.Neuroimage Clin. 2019;24:101991. doi: 10.1016/j.nicl.2019.101991. Epub 2019 Aug 23. Neuroimage Clin. 2019. PMID: 31473545 Free PMC article.
-
Diffusion tensor imaging of brain development.Semin Fetal Neonatal Med. 2006 Dec;11(6):489-97. doi: 10.1016/j.siny.2006.07.006. Epub 2006 Sep 8. Semin Fetal Neonatal Med. 2006. PMID: 16962837 Review.
-
Preterm white matter injury: ultrasound diagnosis and classification.Pediatr Res. 2020 Mar;87(Suppl 1):37-49. doi: 10.1038/s41390-020-0781-1. Pediatr Res. 2020. PMID: 32218534 Free PMC article. Review.
Cited by
-
Early neuroimaging and ultrastructural correlates of injury outcome after neonatal hypoxic-ischaemia.Brain Commun. 2021 Mar 26;3(2):fcab048. doi: 10.1093/braincomms/fcab048. eCollection 2021. Brain Commun. 2021. PMID: 33981995 Free PMC article.
-
Akt/mTOR Pathway Agonist SC79 Inhibits Autophagy and Apoptosis of Oligodendrocyte Precursor Cells Associated with Neonatal White Matter Dysplasia.Neurochem Res. 2024 Mar;49(3):670-683. doi: 10.1007/s11064-023-04057-w. Epub 2023 Nov 28. Neurochem Res. 2024. PMID: 38015410 Free PMC article.
-
A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials.J Neuroinflammation. 2023 Oct 20;20(1):241. doi: 10.1186/s12974-023-02911-w. J Neuroinflammation. 2023. PMID: 37864272 Free PMC article. Review.
-
Interleukin-1: an important target for perinatal neuroprotection?Neural Regen Res. 2023 Jan;18(1):47-50. doi: 10.4103/1673-5374.341044. Neural Regen Res. 2023. PMID: 35799507 Free PMC article. Review.
-
Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models.Front Cell Dev Biol. 2020 Feb 18;8:27. doi: 10.3389/fcell.2020.00027. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32133356 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources